Lidocaine inhibits the progression of retinoblastoma in�vitro and in�vivo by modulating the miR‑520a‑3p/EGFR axis

Weiyi Xia, Libo Wang, Dongyi Yu, Xing Mu, Xin Zhou

DOI: 10.3892/mmr.2019.10363
Published: 2019-06-06
Container: Molecular Medicine Reports
Publisher: Spandidos Publications
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3892/mmr.2019.10363,
  title = {Lidocaine inhibits the progression of retinoblastoma in�vitro and in�vivo by modulating the miR‑520a‑3p/EGFR axis},
  author = {Weiyi Xia and Libo Wang and Dongyi Yu and Xing Mu and Xin Zhou},
  year = {2019},
  journal = {Molecular Medicine Reports},
  doi = {10.3892/mmr.2019.10363},
  url = {https://doi.org/10.3892/mmr.2019.10363}
}

RIS

TY  - JOUR
TI  - Lidocaine inhibits the progression of retinoblastoma in�vitro and in�vivo by modulating the miR‑520a‑3p/EGFR axis
AU  - Weiyi Xia
AU  - Libo Wang
AU  - Dongyi Yu
AU  - Xing Mu
AU  - Xin Zhou
PY  - 2019
JO  - Molecular Medicine Reports
DO  - 10.3892/mmr.2019.10363
UR  - https://doi.org/10.3892/mmr.2019.10363
ER  -

APA

Xia, W., Wang, L., Yu, D., Mu, X., & Zhou, X. (2019). Lidocaine inhibits the progression of retinoblastoma in�vitro and in�vivo by modulating the miR‑520a‑3p/EGFR axis. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2019.10363

Source records

crossref · retrieved 2026-09-25T06:04:04.049Z